MLAB (Mesa Laboratories) Total Stockholders Equity: $186.2 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MLAB Mesa Laboratories Inc MLAB
77 GF Score
Price $97.84
GF Value $116.33
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Mesa Laboratories Total Stockholders Equity?

Mesa Laboratories MLAB -1.49% 77 Total Stockholders Equity is $186.2 Mil as of Mar. 2026. GuruFocus rates MLAB with a GF Score™ of 77/100 and a GF Value™ of $116.33 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Mesa Laboratories's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $186.2 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Mesa Laboratories's Book Value per Share for the quarter that ended in Mar. 2026 was $33.71. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Mesa Laboratories's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.83.

Mesa Laboratories  (NAS:MLAB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Mesa Laboratories's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(186.245-0)/5.525
=33.71

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Mesa Laboratories's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(9.312 + 145.857) / 186.245
=0.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mesa Laboratories Total Stockholders Equity Related Terms

Mesa Laboratories Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Mesa Laboratories's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mesa Laboratories Total Stockholders Equity Chart

Mesa Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 393.80 393.48 145.39 159.83 186.25

Mesa Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 159.83 172.50 178.47 186.69 186.25
MLAB
77GF Score
Mesa Laboratories Inc MLAB
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $186.2 Mil mean?
Mesa Laboratories (MLAB) has a Total Stockholders Equity of $186.2 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Mesa Laboratories and its competitors.
Is Mesa Laboratories' Total Stockholders Equity too high?
Mesa Laboratories' current Total Stockholders Equity is $186.2 Mil. Overall, Mesa Laboratories has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mesa Laboratories' Total Stockholders Equity compare to AERG and USBC?
Mesa Laboratories' Total Stockholders Equity of $186.2 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Hardware company?
A good Total Stockholders Equity depends on the Hardware industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Mesa Laboratories and its competitors. Mesa Laboratories's current Total Stockholders Equity is $186.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mesa Laboratories (MLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is $116.33, compared to a current price of $97.84 — trading 15.9% below its estimated fair value. The current Total Stockholders Equity is $186.2 Mil. Mesa Laboratories' overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Mesa Laboratories (MLAB), the current Total Stockholders Equity is $186.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mesa Laboratories (MLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Mesa Laboratories stock appears to be undervalued. The current stock price of $97.84 is trading 15.9% below its estimated GF Value™ of $116.33. GuruFocus considers Mesa Laboratories to be Modestly Undervalued.

Key valuation signals for MLAB:

  • Total Stockholders Equity: $186.2 Mil
  • GF Value™: $116.33 vs. price of $97.84 (15.9% below fair value)
  • GF Score™: 77/100 with 8 warning signs

No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mesa Laboratories Business Description

Address 12100 West Sixth Avenue, Lakewood, CO, USA, 80228
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
77GF Score

Get the complete analysis for MLAB

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$97.84
Price
$116.33
GF Value